We then apply this technique to two distinct prostate disease models: growth of the prostate in a prolactin-driven benign prostatic hyperplasia model [22], and growth of human prostate cancer orthotopic xenografts implanted in the anterior lobe of the mouse prostate [23]. Here, PRL is linked to prostate cancer.